Andreas Rummelt Email & Phone Number

Andreas Rummelt Work

• 2017 -now Chairman @ InterPharmaLink AG
• 2013 -now Member of the Board of Directors @ Cypralis Limited (July 2013), Alvogen (April 2016), Leukocare AG (July 2016)
• 2021 -2025 Member of the Board of Directors @ AstraZeneca
• 2012 -2024 Member of the Board of Directors @ Xellia Pharmaceuticals A/S
• 2020 -2023 Member of the Board of Directors @ PolgenX A (Holding company of Polyplus-transfection)
• 2020 -2023 Member of the Scientific Advisory Committee @ Global Antibiotic R&D Partnership (GARDP)
• 2011 -2023 Managing Partner @ InterPharmaLink AG, Basel
• 2010 -2021 Member of the Board of Directors @ Alexion Pharmaceuticals, Inc.
• 2013 -2018 Member of the Board of Directors @ Habasit
• 2011 -2013 Member of the Board of Directors @ Acino Holding AG
• 2008 -2010 Group Head Quality Assurance and Technical Operations, Member of the Novartis Executive Committee @ Novartis AG
• 2004 -2008 CEO Sandoz, Member of the Novartis Executive Committee @ Novartis AG
• 1999 -2004 Global Head Technical Operations, Member of the Pharma Executive Committee @ Novartis Pharma AG
• 1997 -1999 Global Head Technical Research and Development, Novartis Pharma Development, Basel and Switzerland @ Novartis Pharma AG
• 1994 -1996 Global Head Technical Research and Development, Sandoz Pharma Development, Basel and Switzerland @ Sandoz AG
• 1985 -1993 Laboratory Head, Group Head, Department Head Drug Delivery Systems, Sandoz Pharma Development Basel and @ Sandoz AG